# LOTEMAX
> **NDA020841** · New Drug Application · Sponsor: PHARMOS · Approved 1998-03-09
## Drug
- **FDA Application Number:** NDA020841
- **Application type:** New Drug Application
- **Brand name:** LOTEMAX
- **Generic name:** Loteprednol Etabonate
- **Active ingredients:** LOTEPREDNOL ETABONATE
- **Dosage form:** SUSPENSION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Discontinued
- **Sponsor:** PHARMOS
- **First approval:** 1998-03-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020841)
---
*AI Analytics · CC0 1.0*